UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 10-K ____________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaw ...

AMN Healthcare Services, Inc. (NYSE:AMN) Q4 2019 Earnings Conference Call February 13, 2020 5:00 PM ET Company Participants Randle Reece - Director IR Susan Salka - President, Chief Executive Officer Brian Scott - Chief Financial Officer, Chief Accounting Officer & Treasurer Kelly Rakowski - President of Leadership & Search Solutions Ralph Henderson - President of Professional Services & Staffing Dan White - President of Strategic Workforce Solutions Conference Call Participants Tobey Sommer - SunTrust Cale ...

PART I - FINANCIAL INFORMATION [Item 1. Condensed Consolidated Financial Statements](index=4&type=section&id=Item%201.%20Condensed%20Consolidated%20Financial%20Statements) The unaudited statements show increased assets and liabilities from acquisitions and a new lease standard, with higher Q3 revenue but lower net income [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets grew to $1.86 billion and liabilities to $1.16 billion, driven by acquisition-related goodwill and new operating lease liabilities Condensed Consolidated Balance Sheet Highlights (in thousands) | Balance Sheet Item | Sep 30, 2019 | Dec 31, 2018 | | :--- | :--- | :--- | | **Total Assets** | **$1,861,074** | **$1,492,721** | | Goodwill | $586,611 | $438,506 | | Intangible assets, net | $400,428 | $326,147 | | **Total Liabilities** | **$1,155,970** | **$853,731** | | Notes payable, less unamortized fees | $465,899 | $320,607 | | Operating lease liabilities | $107,537 | $0 | | **Total Stockholders' Equity** | **$705,104** | **$638,990** | [Condensed Consolidated Statements of Comprehensive Income](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) Q3 2019 revenue grew 7.7% to $567.6 million, while net income declined 15.8% to $23.5 million year-over-year Q3 and Nine Months Performance (in thousands, except per share amounts) | Metric | Q3 2019 | Q3 2018 | YTD 2019 | YTD 2018 | | :--- | :--- | :--- | :--- | :--- | | Revenue | $567,597 | $526,842 | $1,635,215 | $1,607,439 | | Gross Profit | $190,031 | $175,147 | $546,332 | $523,927 | | Income from Operations | $39,739 | $42,635 | $129,947 | $152,651 | | Net Income | $23,515 | $27,918 | $86,506 | $106,128 | | Diluted EPS | $0.49 | $0.58 | $1.82 | $2.17 | [Condensed Consolidated Statements of Stockholders' Equity](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Stockholders'%20Equity) Stockholders' equity increased to $705.1 million, driven by net income and partially offset by common stock repurchases - Retained earnings increased by **$86.5 million** from net income for the nine months ended September 30, 2019[10](index=10&type=chunk) - The company repurchased common stock for **$17.9 million** in the first quarter of 2019 and **$0.8 million** in the second quarter[10](index=10&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=9&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Operating cash flow decreased, while significant cash was used for acquisitions, funded primarily by new debt financing Cash Flow Summary (Nine Months Ended Sep 30, in thousands) | Cash Flow Activity | 2019 | 2018 | | :--- | :--- | :--- | | Net cash provided by operating activities | $146,205 | $168,046 | | Net cash used in investing activities | ($253,606) | ($271,648) | | Net cash provided by financing activities | $136,440 | $81,774 | | **Net increase (decrease) in cash** | **$28,981** | **($21,623)** | - The company paid **$228.2 million** for acquisitions in the first nine months of 2019, compared to $217.4 million in the same period of 2018[12](index=12&type=chunk) [Notes to Unaudited Condensed Consolidated Financial Statements](index=11&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) Notes detail the adoption of a new lease standard, acquisitions, segment data, debt changes, and a subsequent $300 million note issuance - The company adopted the new lease standard ASU 2016-02 on January 1, 2019, recognizing operating lease right-of-use assets of **$99.5 million** and lease liabilities of **$114.8 million**[20](index=20&type=chunk)[21](index=21&type=chunk) - In 2019, the company acquired Advanced Medical Personnel Services for **$211.8 million** and Silversheet, Inc for **$31.7 million**[27](index=27&type=chunk)[30](index=30&type=chunk) - Subsequent to the quarter end, on October 1, 2019, the company issued **$300 million** of 4.625% Senior Notes due 2027 and used the proceeds to repay existing debt[82](index=82&type=chunk)[83](index=83&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=26&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Q3 revenue rose 8% to $567.6 million, driven by acquisitions and the nurse segment, despite a decline in locum tenens solutions Q3 2019 Revenue by Segment (in millions) | Segment | Q3 2019 Revenue | Q3 2018 Revenue | % Change | | :--- | :--- | :--- | :--- | | Nurse and allied solutions | $362.5 | $306.3 | +18% | | Locum tenens solutions | $84.2 | $101.1 | -17% | | Other workforce solutions | $120.9 | $119.4 | +1% | | **Total Revenue** | **$567.6** | **$526.8** | **+8%** | - Recent trends indicate **strong overall demand** for healthcare staffing, but the company's nurse supply has not kept pace[93](index=93&type=chunk)[95](index=95&type=chunk) - Demand for locum tenens hospitalists and emergency room physicians has **significantly declined**[96](index=96&type=chunk) - On October 1, 2019, the company issued **$300 million** of 4.625% Senior Notes due 2027 and used the proceeds to repay **$149.1 million** of its term loan and **$146.0 million** of its revolving credit facility[132](index=132&type=chunk)[143](index=143&type=chunk) [Item 3. Quantitative and Qualitative Disclosures about Market Risk](index=37&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) The company's primary market risk is interest rate fluctuation on its variable-rate debt, with foreign currency risk deemed immaterial - The primary market risk is **interest rate risk** associated with variable interest debt[154](index=154&type=chunk) - **Foreign currency risk is deemed immaterial** as the company generates substantially all revenue in the U.S[154](index=154&type=chunk) [Item 4. Controls and Procedures](index=37&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective, with no material changes to internal controls during the quarter - The CEO and CFO concluded that **disclosure controls and procedures were effective** as of September 30, 2019[155](index=155&type=chunk) - **No material changes** to internal control over financial reporting occurred during the quarter ended September 30, 2019[156](index=156&type=chunk) PART II - OTHER INFORMATION [Item 1. Legal Proceedings](index=38&type=section&id=Item%201.%20Legal%20Proceedings) The company reported no material legal proceedings for the period - None[156](index=156&type=chunk) [Item 1A. Risk Factors](index=39&type=section&id=Item%201A.%20Risk%20Factors) No material changes were reported to the risk factors previously disclosed in the 2018 Annual Report on Form 10-K - There have been **no material changes** to the risk factors disclosed in the 2018 Annual Report[157](index=157&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=39&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company repurchased 395,212 shares for $18.7 million, with $30.9 million remaining under the repurchase authorization Share Repurchases (Nine Months Ended Sep 30, 2019) | Metric | Value | | :--- | :--- | | Total Shares Repurchased | 395,212 | | Average Price Paid per Share | $47.30 | | Total Purchase Price | $18.7 million | | Remaining Authorization | $30.9 million | [Item 3. Defaults Upon Senior Securities](index=39&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reported no defaults upon its senior securities - None[160](index=160&type=chunk) [Item 4. Mine Safety Disclosures](index=39&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company's business - Not applicable[161](index=161&type=chunk) [Item 5. Other Information](index=39&type=section&id=Item%205.%20Other%20Information) The company reported no other information required to be disclosed - None[161](index=161&type=chunk) [Item 6. Exhibits](index=40&type=section&id=Item%206.%20Exhibits) This section lists filed exhibits, including the Indenture for new senior notes and Sarbanes-Oxley certifications - Key exhibits filed include the **Indenture for the new 2027 Senior Notes** and CEO/CFO certifications[163](index=163&type=chunk)

AMN Healthcare Services, Inc. (NYSE:AMN) Q3 2019 Earnings Conference Call October 31, 2019 5:00 PM ET Company Participants Randle Reece - Director IR Susan Salka - President & CEO Brian Scott - CAO, CFO & Treasurer Ralph Henderson - President of Professional Services & Staffing Dan White - President of Strategic Workforce Solutions Kelly Rakowski - President of Leadership & Search Solutions Conference Call Participants Jeff Silber - BMO Capital Markets A.J. Rice - Credit Suisse Mark Marcon - R.W. Baird Jaso ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 10-Q ____________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware ...

AMN Healthcare Services, Inc. (NYSE:AMN) Q2 2019 Results Earnings Conference Call August 6, 2019 5:00 PM ET Company Participants Randle Reece - Director of IR Susan Salka - President, CEO Brian Scott - CAO, CFO & Treasurer Dan White - President of Strategic Workforce Solutions Kelly Rakowski - President of Leadership & Search Solutions Ralph Henderson - President of Professional Services & Staffing Conference Call Participants Jason Plagman - Jefferies and Company Tobey Sommer - SunTrust A.J. Rice - Credit ...

Financial Data and Key Metrics Changes - The company's first quarter consolidated revenue was $532 million, representing a 2% year-over-year growth and $4 million above the high end of guidance [10][21] - Gross margin for the quarter was 33.2%, up 110 basis points from the previous year and 60 basis points better than the prior quarter [21] - Adjusted EBITDA was $66 million, down 1% year-over-year, with an adjusted EBITDA margin of 12.4%, lower by 30 basis points year-over-year [24] Business Line Data and Key Metrics Changes - Nurse and Allied segment revenue was $337 million, flat year-over-year, with a gross margin of 27.9%, down 10 basis points from the prior year [11][22] - Locum Tenens segment revenue was $80 million, down 22% year-over-year, with a gross margin of 27.7%, down 100 basis points from the prior year [13][23] - Other Workforce Solutions segment revenue was $115 million, up 42% year-over-year, primarily due to acquisitions, with a gross margin of 52.6%, lower by 100 basis points year-over-year [15][23] Market Data and Key Metrics Changes - The labor market in healthcare remains tight, with vacancies at all-time highs and turnover in double digits [9] - Orders in staffing businesses have risen, particularly in travel nursing, Allied, and interim leadership, with travel nurse orders currently up more than 25% compared to the prior year [9][11] - The company signed new MSP and expanded existing MSP relationships totaling over $150 million in gross spend under management [9] Company Strategy and Development Direction - The company announced the acquisition of Advanced Medical for $200 million, which is expected to enhance its capabilities in therapy staffing and teletherapy services [7][27] - The company is focused on making investments in technology and digital capabilities to better serve clients and healthcare professionals [18] - The strategic partnerships being built with large healthcare organizations are seen as a positive indicator of the company's positioning in the market [17] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the demand for travel therapy and nursing, indicating that the demand environment is strong and expected to remain so [9][17] - The company anticipates total Nurse and Allied segment revenue to be down 3% to 4% year-over-year in the second quarter, primarily due to a labor disruption event in the prior year [13][28] - Management noted that the current order trends and economic indicators suggest that a slowdown is not likely in the near term [17] Other Important Information - The company repurchased 378,000 shares for $18 million during the quarter and has added $150 million to its share repurchase authorization [26] - Total debt outstanding was $475 million, with a leverage ratio of 1.9x:1 [26] Q&A Session Summary Question: What is driving the strength in Nursing and Allied? - Management indicated that growth is seen across various relationships, with a lift in the marketplace and some share movement due to recent large MSP wins [31] Question: How is the premium rate anniversary impacting results? - Management confirmed that the average bill rate in Nursing was down about 1% in the first quarter, but they expect it to stabilize in the second quarter [34] Question: What is the outlook for the Locum segment? - The Locum segment is expected to grow about 2% sequentially in the second quarter, but still down significantly year-over-year [14] Question: Can you provide insights on the Advanced acquisition? - The acquisition is expected to enhance the company's capabilities in hard-to-fill specialties and provide opportunities for innovation in teletherapy and school staffing [56][62] Question: What is the growth rate of Advanced Medical? - Advanced Medical is expected to see double-digit growth in its Allied business and significant growth in its school staffing segment [62]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 10-Q ____________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware ...